10x Genomics (TXG) Shares Outstanding (2018 - 2026)

10x Genomics' Shares Outstanding history runs 9 years deep, the most recent figure standing at $129.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 4.75% year-over-year to $129.0 million; the TTM figure through Mar 2026 stood at $129.0 million (up 4.75% YoY), while the FY2025 annual figure was $127.7 million, up 4.42% from the prior year.
• Shares Outstanding came in at $129.0 million for Q1 2026 at 10x Genomics, up from $127.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $129.0 million in Q1 2026 to a low of $113.3 million in Q1 2022.
• A 5-year average of $120.1 million and a median of $119.7 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding grew 2.38% in 2022 and increased 4.75% in 2026, its largest moves.
• 10x Genomics' Shares Outstanding stood at $115.2 million in 2022, then climbed by 3.39% to $119.1 million in 2023, then gained by 2.68% to $122.3 million in 2024, then advanced by 4.42% to $127.7 million in 2025, then increased by 1.02% to $129.0 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $129.0 million, $127.7 million, and $126.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison